...
首页> 外文期刊>Cancers >Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model
【24h】

Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model

机译:通过机器学习模型开发上皮性卵巢癌患者的预后基因组

获取原文
           

摘要

Epithelial ovarian cancer patients usually relapse after primary management. We utilized the support vector machine algorithm to develop a model for the chemo-response using the Cancer Cell Line Encyclopedia (CCLE) and validated the model in The Cancer Genome Atlas (TCGA) and the GSE9891 dataset. Finally, we evaluated the feasibility of the model using ovarian cancer patients from our institute. The 10-gene predictive model demonstrated that the high response group had a longer recurrence-free survival (RFS) (log-rank test, p = 0.015 for TCGA, p = 0.013 for GSE9891 and p = 0.039 for NTUH) and overall survival (OS) (log-rank test, p = 0.002 for TCGA and p = 0.016 for NTUH). In a multivariate Cox hazard regression model, the predictive model (HR: 0.644, 95% CI: 0.436–0.952, p = 0.027) and residual tumor size 1 cm (HR: 0.312, 95% CI: 0.170–0.573, p 0.001) were significant factors for recurrence. The predictive model (HR: 0.511, 95% CI: 0.334–0.783, p = 0.002) and residual tumor size 1 cm (HR: 0.252, 95% CI: 0.128–0.496, p 0.001) were still significant factors for death. In conclusion, the patients of high response group stratified by the model had good response and favourable prognosis, whereas for the patients of medium to low response groups, introduction of other drugs or clinical trials might be beneficial.
机译:上皮性卵巢癌患者通常在一级处理后复发。我们利用支持向量机算法使用癌细胞系百科全书(CCLE)开发化学反应模型,并在癌症基因组图谱(TCGA)和GSE9891数据集中验证了该模型。最后,我们使用我们研究所的卵巢癌患者评估了该模型的可行性。具有10个基因的预测模型表明,高应答组的无复发生存期(RFS)较长(对数秩检验,TCGA p = 0.015,GSE9891 p = 0.013,NTUH p = 0.039)和总体生存率( OS)(对数秩检验,对于TCGA,p = 0.002,对于NTUH,p = 0.016)。在多变量Cox风险回归模型中,采用预测模型(HR:0.644,95%CI:0.436–0.952,p = 0.027)和残余肿瘤尺寸<1 cm(HR:0.312,95%CI:0.170–0.573,p < 0.001)是复发的重要因素。预测模型(HR:0.511,95%CI:0.334-0.783,p = 0.002)和残余肿瘤尺寸<1 cm(HR:0.252,95%CI:0.128-0.496,p <0.001)仍然是死亡的重要因素。综上所述,按模型分层的高反应组患者反应良好,预后良好,而中低反应组患者则可采用其他药物或进行临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号